NSclc Treatment

November 17, 2021

Bemcentinib – Keytruda Combination in NSCLC

Charles H. Weaver, MD
April 13, 2021

Treatment of Stage I – III Non-Small Cell Lung Cancer

Charles H. Weaver, MD
March 30, 2021

Enhertu Treatment of Her2 positive Non-Small Cell Lung Cancer

Charles H. Weaver, MD
March 21, 2021

Tecentriq® Improves Survival in Early and Advanced Stage NSCLC

Charles H. Weaver, MD
February 17, 2021

Treatment & Management of Non Small Cell Lung Cancer

Charles H. Weaver, MD
February 6, 2021

Treatment of Stage III B – IV Non-Small Cell Lung Cancer

Charles H. Weaver, MD
February 2, 2021

Tepmetko Treatment for Non Small Cell Lung Cancer

Charles H. Weaver, MD
September 22, 2020

Gavreto Treatment for RET Fusion-Positive Non-Small Cell Lung Cancer

Charles H. Weaver, MD
September 4, 2020

Tabrecta™ (capmatinib) Targets the Exon 14 Skipping Mutation in NSCLC

Charles H. Weaver, MD
June 3, 2020

Cyramza Improves Overall Survival and Delays Cancer Recurrence in NSCLC

Charles H. Weaver, MD
November 2, 2019

Treatment of Recurrent Non-Small Cell Lung Cancer

Charles H. Weaver, MD
July 6, 2019

BLU-667 Treatment of RET Fusion-positive Non-Small Cell Lung Cancer

Charles H. Weaver, MD